Companion Diagnostic Technologies Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War

Companion Diagnostic Technologies Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War


The global companion diagnostic technologies market is expected to grow at a CAGR of around 12.4% during 2025-2034. This report on global companion diagnostic technologies market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global companion diagnostic technologies market by segmenting the market based on technology, indication and region. Also, detailed profiles of companies operating in the companion diagnostic technologies market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Increased Advancement for Personalized Medicines
• Increasing Cases of Drug Reactions

Market Challenges

• High Drug Development Costs

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Technology

• Immunohistochemistry (IHC)
• Polymerase Chain Reaction (PCR)
• In-situ Hybridization (ISH)
• Real-time PCR (RT-PCR)
• Gene Sequencing
• Other Technologies

Market by Indication

• Lung Cancer
• Breast Cancer
• Neurological Diseases
• Infectious Diseases
• Other Indications

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa


1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Companion Diagnostic Technologies Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Companion Diagnostic Technologies Market Analysis
4.1. Market Portraiture
4.2. Market Technology
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Companion Diagnostic Technologies Market by Technology
5.1. Introduction
5.2. Immunohistochemistry (IHC)
5.3. Polymerase Chain Reaction (PCR)
5.4. In-situ Hybridization (ISH)
5.5. Real-time PCR (RT-PCR)
5.6. Gene Sequencing
5.7. Other Technologies
6. Global Companion Diagnostic Technologies Market by Indication
6.1. Introduction
6.2. Lung Cancer
6.3. Breast Cancer
6.4. Neurological Diseases
6.5. Infectious Diseases
6.6. Other Indications
7. Global Companion Diagnostic Technologies Market by Region
7.1. Introduction
7.2. Europe
7.2.1. Germany
7.2.2. United Kingdom
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Russia
7.2.7. Netherlands
7.2.8. Rest of the Europe
7.3. North America
7.3.1. United States
7.3.2. Canada
7.4. Asia Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. South Korea
7.4.5. Australia
7.4.6. Indonesia
7.4.7. Rest of the Asia Pacific
7.5. Latin America
7.5.1. Mexico
7.5.2. Brazil
7.5.3. Argentina
7.5.4. Rest of Latin America
7.6. Middle East & Africa
7.6.1. Saudi Arabia
7.6.2. Turkey
7.6.3. Iran
7.6.4. United Arab Emirates
7.6.5. Rest of Middle East & Africa
8. SWOT Analysis
9. Porter’s Five Forces
10. Market Value Chain Analysis
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Company Profiles
11.2.1. Abbott Laboratories Inc.
11.2.2. Abnova Corporation
11.2.3. Agilent Technologies Inc.
11.2.4. Almac Group
11.2.5. Biogenex Laboratories Inc.
11.2.6. Biomerieux SA
11.2.7. Danaher Corporation (Beckman Coulter Inc.)
11.2.8. F.Hoffmann-La Roche Ltd
11.2.9. Guardant Health Inc.
11.2.10. Illumina Inc.
11.2.11. Myriad Genetics Inc.
11.2.12. Qiagen NV
11.2.13. Siemens Healthcare
11.2.14. Sysmex Corporation
11.2.15. Thermo Fisher Scientific Inc.
List of Figures
Figure 1: Global Companion Diagnostic Technologies Market (in US$ Million), 2020-2024
Figure 2: Global Companion Diagnostic Technologies Market by Technology, 2024
Figure 3: Global Companion Diagnostic Technologies Market by Indication, 2024
Figure 4: Global Companion Diagnostic Technologies Market by Region, 2024
Figure 5: Global Companion Diagnostic Technologies Market (in US$ Million), 2025-2034
Figure 6: Global Companion Diagnostic Technologies Market by Technology (in %), 2024 & 2034
Figure 7: Global Immunohistochemistry (IHC) Companion Diagnostic Technologies Market (in US$ Million), 2020-2024
Figure 8: Global Immunohistochemistry (IHC) Companion Diagnostic Technologies Market (in US$ Million), 2025-2034
Figure 9: Global Polymerase Chain Reaction (PCR) Companion Diagnostic Technologies Market (in US$ Million), 2020-2024
Figure 10: Global Polymerase Chain Reaction (PCR) Companion Diagnostic Technologies Market (in US$ Million), 2025-2034
Figure 11: Global In-situ Hybridization (ISH) Companion Diagnostic Technologies Market (in US$ Million), 2020-2024
Figure 12: Global In-situ Hybridization (ISH) Companion Diagnostic Technologies Market (in US$ Million), 2025-2034
Figure 13: Global Real-time PCR (RT-PCR) Companion Diagnostic Technologies Market (in US$ Million), 2020-2024
Figure 14: Global Real-time PCR (RT-PCR) Companion Diagnostic Technologies Market (in US$ Million), 2025-2034
Figure 15: Global Gene Sequencing Companion Diagnostic Technologies Market (in US$ Million), 2020-2024
Figure 16: Global Gene Sequencing Companion Diagnostic Technologies Market (in US$ Million), 2025-2034
Figure 17: Global Other Technologies Companion Diagnostic Technologies Market (in US$ Million), 2020-2024
Figure 18: Global Other Technologies Companion Diagnostic Technologies Market (in US$ Million), 2025-2034
Figure 19: Global Companion Diagnostic Technologies Market by Indication (in %), 2024 & 2034
Figure 20: Global Lung Cancer Companion Diagnostic Technologies Market (in US$ Million), 2020-2024
Figure 21: Global Lung Cancer Companion Diagnostic Technologies Market (in US$ Million), 2025-2034
Figure 22: Global Breast Cancer Companion Diagnostic Technologies Market (in US$ Million), 2020-2024
Figure 23: Global Breast Cancer Companion Diagnostic Technologies Market (in US$ Million), 2025-2034
Figure 24: Global Neurological Diseases Companion Diagnostic Technologies Market (in US$ Million), 2020-2024
Figure 25: Global Neurological Diseases Companion Diagnostic Technologies Market (in US$ Million), 2025-2034
Figure 26: Global Infectious Diseases Companion Diagnostic Technologies Market (in US$ Million), 2020-2024
Figure 27: Global Infectious Diseases Companion Diagnostic Technologies Market (in US$ Million), 2025-2034
Figure 28: Global Other Indication Companion Diagnostic Technologies Market (in US$ Million), 2020-2024
Figure 29: Global Other Indication Companion Diagnostic Technologies Market (in US$ Million), 2025-2034
Figure 30: Global Companion Diagnostic Technologies Market by Region (in %), 2024 & 2034
Figure 31: Europe Companion Diagnostic Technologies Market (in US$ Million), 2020-2024
Figure 32: Europe Companion Diagnostic Technologies Market (in US$ Million), 2025-2034
Figure 33: Europe Companion Diagnostic Technologies Market by Country (in %), 2024 & 2034
Figure 34: Germany Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 35: United Kingdom Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 36: France Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 37: Italy Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 38: Spain Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 39: Russia Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 40: Netherlands Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 41: North America Companion Diagnostic Technologies Market (in US$ Million), 2020-2024
Figure 42: North America Companion Diagnostic Technologies Market (in US$ Million), 2025-2034
Figure 43: North America Companion Diagnostic Technologies Market by Country (in %), 2024 & 2034
Figure 44: United States Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 45: Canada Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 46: Asia Pacific Companion Diagnostic Technologies Market (in US$ Million), 2020-2024
Figure 47: Asia Pacific Companion Diagnostic Technologies Market (in US$ Million), 2025-2034
Figure 48: Asia Pacific Companion Diagnostic Technologies Market by Country (in %), 2024 & 2034
Figure 49: China Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 50: Japan Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 51: India Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 52: South Korea Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 53: Australia Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 54: Indonesia Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 55: Latin America Companion Diagnostic Technologies Market (in US$ Million), 2020-2024
Figure 56: Latin America Companion Diagnostic Technologies Market (in US$ Million), 2025-2034
Figure 57: Latin America Companion Diagnostic Technologies Market by Country (in %), 2024 & 2034
Figure 58: Mexico Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 59: Brazil Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 60: Argentina Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 61: Middle East & Africa Companion Diagnostic Technologies Market (in US$ Million), 2020-2024
Figure 62: Middle East & Africa Companion Diagnostic Technologies Market (in US$ Million), 2025-2034
Figure 63: Middle East & Africa Companion Diagnostic Technologies Market by Country (in %), 2024 & 2034
Figure 64: Saudi Arabia Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 65: Turkey Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 66: Iran Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 67: UAE Companion Diagnostic Technologies Market (in US$ Million), 2020-2034
Figure 68: Market Value Chain
List of Tables
Table 1: Global Companion Diagnostic Technologies Market Portraiture
Table 2: Global Companion Diagnostic Technologies Market by Technology (in US$ Million), 2024 & 2034
Table 3: Global Companion Diagnostic Technologies Market by Indication (in US$ Million), 2024 & 2034
Table 4: Global Companion Diagnostic Technologies Market by Region (in US$ Million), 2024 & 2034
Table 5: Europe Companion Diagnostic Technologies Market by Country (in US$ Million), 2024 & 2034
Table 6: North America Companion Diagnostic Technologies Market by Country (in US$ Million), 2024 & 2034
Table 7: Asia Pacific Companion Diagnostic Technologies Market by Country (in US$ Million), 2024 & 2034
Table 8: Latin America Companion Diagnostic Technologies Market by Country (in US$ Million), 2024 & 2034
Table 9: Middle East & Africa Companion Diagnostic Technologies Market by Country (in US$ Million),
2024 & 2034
Table 10: List of Key Players

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings